Leonardo S. De Araujo

Borstel-hohenraden, SH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Using genomic epidemiology and geographic activity spaces to investigate tuberculosis outbreaks in Botswana.

Using genomic epidemiology and geographic activity spaces to investigate tuberculosis outbreaks in Botswana.

Journal: International journal of health geographics

Published: October 10, 2025

Using genomic epidemiology and geographic activity spaces to investigate tuberculosis outbreaks in Botswana.

Using genomic epidemiology and geographic activity spaces to investigate tuberculosis outbreaks in Botswana.

Journal: medRxiv : the preprint server for health sciences

Published: December 16, 2024

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.

Journal: Nature communications

Published: September 13, 2024

Differential transcriptomic host responses in the early phase of viral and bacterial infections in human lung tissue explants ex vivo.

Differential transcriptomic host responses in the early phase of viral and bacterial infections in human lung tissue explants ex vivo.

Journal: Respiratory research

Published: July 02, 2024

Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study.

Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study.

Journal: The Lancet. Infectious diseases

Published: April 21, 2023

Use of High-Resolution Geospatial and Genomic Data to Characterize Recent Tuberculosis Transmission, Botswana.

Use of High-Resolution Geospatial and Genomic Data to Characterize Recent Tuberculosis Transmission, Botswana.

Journal: Emerging infectious diseases

Published: April 20, 2023

Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial outcomes.

Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial outcomes.

Journal: Frontiers in public health

Published: April 11, 2023

Genomic epidemiology of SARS-CoV-2 during the first four waves in Mozambique.

Genomic epidemiology of SARS-CoV-2 during the first four waves in Mozambique.

Journal: PLOS global public health

Published: September 28, 2022

Transcriptomic Biomarkers for Tuberculosis: Validation of NPC2 as a Single mRNA Biomarker to Diagnose TB, Predict Disease Progression, and Monitor Treatment Response.

Transcriptomic Biomarkers for Tuberculosis: Validation of NPC2 as a Single mRNA Biomarker to Diagnose TB, Predict Disease Progression, and Monitor Treatment Response.

Journal: Cells

Published: August 20, 2021

Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.

Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.

Journal: mBio

Published: December 05, 2019

Phosphatidylcholine PC ae C44:6 in cerebrospinal fluid is a sensitive biomarker for bacterial meningitis.

Phosphatidylcholine PC ae C44:6 in cerebrospinal fluid is a sensitive biomarker for bacterial meningitis.

Journal: Journal of translational medicine

Published: August 22, 2019

Transcriptomic Biomarkers for Tuberculosis: Evaluation of DOCK9. EPHA4, and NPC2 mRNA Expression in Peripheral Blood.

Transcriptomic Biomarkers for Tuberculosis: Evaluation of DOCK9. EPHA4, and NPC2 mRNA Expression in Peripheral Blood.

Journal: Frontiers in microbiology

Published: July 20, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026